SUMMARY Pancreatic function was studied in 29 patients with extrahepatic portal venous obstruction, and 30 age-matched controls. The aetiology of the portal venous obstruction was known in 20 out of 29 patients. No patient had a history of pancreatitis. Serum trypsin, both fasting and for 120 minutes after a Lundh meal, was significantly lower in the patients than in controls (p <0 005). 5/28 (18 %) patients had reduced fasting serum trypsin levels and in 5/14 trypsin was abnormal after a Lundh meal. Mean fasting serum glucose (3.8 ±0 49 mmol/l was significantly higher than in control subjects (mean 3.4 ±0A42 mmol/l) (p <005). After 100 g glucose orally, mean serum glucose at 180 minutes (5.26 ±1.58 mmol/l) was higher than the control value (3.96 +1.45 mmol/l) (p <0 05), and 30 and 60 minutes serum C-peptide values were significantly lower (p <0.005). Pancreatic hypofunction found in these patients probably results from an abnormal portal circulation in association with mild pancreatic damage secondary to chronic venous congestion.
Patients with obstruction to the main portal vein, but with normal liver structure, have venous congestion throughout the splanchnic area. The major clinical effect is the development of a portal systemic collateral circulation with subsequent bleeding, usually from oesophageal varices. Deprivation of portal blood flow to the liver leads to mild hepatic dysfunction which progresses as age advances. ' The effect of portal venous obstruction on pancreatic function, both exocrine and endocrine, has not been studied in man. We have therefore investigated pancreatic exocrine function by serum trypsin measurements both fasting and after a Lundh test meal, and endocrine function by the plasma glucose, insulin, and C-peptide levels. The effect of portalsystemic bypassing on pancreatic endocrine and exocrine secretions has also been considered.
Results in 29 patients with extrahepatic portal venous obstruction have been compared with those in 30 age-matched control subjects.
Methods
Twenty-nine patients aged from 16 to 63 years and 30 age matched control subjects were studied. The aetiology of the portal vein obstruction was known in 20 out of the 29 patients (Table ) . Liver biopsy Received for publication 10 October 1979 in all patients showed normal hepatic architecture and blood urea and creatinine levels were normal in all patients and controls. No patient had a history of diabetes or steatorrhoea and only one suffered from abdominal pain. The diagnosis of extrahepatic portal venous obstruction was confirmed by portal venography. The controls were volunteers, medical or laboratory staff, or hospital inpatients with no history of gastrointestinal or endocrine disease.
Fifteen patients and 18 controls, after an overnight fast, received a Lundh test meal.2 Venous blood was drawn for analysis of trypsin levels at 0, 30, 60, 90, and 120 minutes after ingestion of the meal. The serum trypsin was measured by radjoimmunoassay (Hoechst RIA-gnost trypsin, Behringwerke, Marburg). In 13 additional patients the fasting trypsin level was measured. Nineteen patients and 12 controls, with no previous history of gastric surgery or endocrine disease, after 24 hours bed rest in hospital and an overnight fast received 100 g glucose orally.
Venous blood was taken for glucose, C-peptide and insulin estimations before and 30, 60, 90, 150, and 180 minutes after glucose ingestion. Plasma insulin and C-peptide levels were measured by radioimmunoassay.3 4 In 22 patients the pancreas was scanned by greyscale ultrasonography.
Twenty-six of the 28 patients' weights fell within 10% ideal body weight, including the 19 patients (Fig. 1) . Five of the 14 patients had reduced trypsin levels (Fig. 2) . The mean fasting serum glucose for the patients (38 ±0.42 mmol/1) was significantly greater than the control mean (3.41 ±042 mmol/l, P<0.05, Fig. 3 might also be expected to influence serum trypsin levels after pancreatic stimulation. However, pancreatic hyposecretion would also explain the fall in in serum trypsin which occurred in the patients after a meal, compared with the small rise in controls. Pro-insulin is cleaved in the pancreatic B-cell to insulin and C-peptide, which are released into the circulation in equimolar quantities.13 C-peptide is not degraded by the liver and peripheral levels are a good reflection of pancreatic insulin secretion. 
